Manuscripts
Showing 1552 manuscripts.
Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests
Citation
J. Robins, Dianne M. Finkelstein. Correcting for noncompliance and dependent censoring in an AIDS clinical trial with inverse probability of censoring weighted (IPCW) log-rank tests. Biometrics. 2000. 56: 779-88.Year
2000
Journal
Biometrics
Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks
Citation
Charles Raines, Charles Flexner, Eugene Sun, Margo E. Heath-Chiozzi, Ronald Lewis, Catherine Fields, C. Deetz, Linda Apuzzo, Susan H. Eshleman, Brooks Jackson, Joel E. Gallant. Safety, tolerability, and antiretroviral effects of ritonavir-nelfinavir combination therapy administered for 48 weeks. Journal of Acquired Immune Deficiency Syndromes. 2000. 25: 322-8.Year
2000
Journal
Journal of Acquired Immune Deficiency Syndromes
Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children
Citation
Leock Y. Ngo, Ram Yogev, Wayne M. Dankner, Walter T. Hughes, Sandra Burchett, Jing Xu, Brian Sadler, Jashvant D. Unadkat. Pharmacokinetics of Azithromycin Administered Alone and with Atovaquone in Human Immunodeficiency Virus-Infected Children. Antimicrobial Agents and Chemotherapy. 1999. 43: 1516-19.Year
1999
Journal
Antimicrobial Agents and Chemotherapy
Combination Therapy with Stavudine (d4T) Plus Didanosine (ddI) In Children With Human Immunodeficiency Virus Infection
Citation
Mark W. Kline, Russell B. Van Dyke, Jane C. Lindsey, Meg Gwynne, Mary Culnane, Clemente Diaz, Ram Yogev, Ross E. McKinney, Elaine J. Abrams, Lynne M. Mofenson. Combination Therapy with Stavudine (d4T) Plus Didanosine (ddI) In Children With Human Immunodeficiency Virus Infection. Pediatrics. 1999. 103: e62.Year
1999
Journal
Pediatrics
Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211)
Citation
William T. Shearer, Mark W. Kline, Stuart L. Abramson, Terence Fenton, Stuart E. Starr, Steven D. Douglas. Phase I/II Study of Recombinant Human Interferon-gamma (rIFN-gamma) in HIV-infected Children: Safety, CD4+ Lymphocyte Count, Viral Load, and Neutrophil Function (AIDS Clinical Trials Group Protocol 211). Clinical and Diagnostic Laboratory Immunology. 1999. 6: 311-15.Year
1999
Journal
Clinical and Diagnostic Laboratory Immunology
Interruption Of Materno-Fetal Transmission
Citation
Mofenson LM, Fowler MG. Interruption Of Materno-Fetal Transmission. AIDS. 1999. 13: S205-14. PMID: 10885777Year
1999
Journal
AIDS
Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children
Citation
Stevens RC, Frenkel LM, Rodman JH. Influence Of Age and Food On Didanosine Pharmacokinetics In HIV Infected Children. Pharmacotherapy. 1999. 19: 487.Year
1999
Journal
Pharmacotherapy
Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter)
Citation
Shapiro DE, Sperling RS, Coombs RW. Effect Of Zidovudine On Perinatal HIV-1 Transmission and Maternal Viral Load (Letter). Lancet. 1999. 354: 156.Year
1999
Journal
Lancet
The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1
Citation
GD McSherry, David E. Shapiro, RW Coombs, N Mcgrath, LM Frenkel, Britto P, M Culnane, RS Sperling. The Effects of Zidovudine in the Subset of Infants Infected with Human Immunodeficiency Virus Type-1. Journal of Pediatrics. 1999. 134: 717-24.Year
1999
Journal
Journal of Pediatrics
Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies
Citation
Mark Mirochnick, Edmund Capparelli, James Connor. Pharmacokinetics of Zidovudine in Infants: A Population Analysis Across Studies. Clinical Pharmacology & Therapeutics. 1999. 66: 16-24.Year
1999
Journal
Clinical Pharmacology & Therapeutics